CER Daily Newsfeed

Video: PBM Reform, IRA & The Year Ahead: John O'Brien at The Hill's Health Next Summit

(4/17, The Hill, YouTube) “John O'Brien, President and CEO of National Pharmaceutical Council, joined The Hill at the Health Next Summit. He discussed priorities for the year ahead, unintended consequences of the Inflation Reduction Act (IRA), and what makes PBM reform so important.” View Video

Video: Advancing Health Equity in the Workforce: Kimberly Westrich, MA

(4/17, Pearl Steinzor, Kimberly Westrich, MA, The American Journal of Managed Care) “As a primary source of health insurance for working-age Americans, employers are uniquely positioned to address health inequities affecting their workforce and their families, according to a recent study by the National Pharmaceutical Council (NPC). Therefore, it is important to understand how structural factors—including racism, implicit bias, and affordability barriers—intersect with benefit design and health system performance and how employers can drive meaningful change by adopting equity-focused strategies, advocating for transparency, and fostering more patient-centered care, explained Kimberly Westrich, MA, chief strategy officer, NPC.” View Video

Bridging Research to Practice: PCORI's HSII Program Transforms Patient Care

(4/17, PCORI Blog) comments “...HSII exemplifies how patient-centered comparative clinical effectiveness research (CER) can drive real-world change. With 42 health systems across 31 states and the District of Columbia participating, this multi-year initiative supports implementation projects across four critical areas, embedding evidence from PCORI-funded CER into care delivery. Backed by organizational leadership and deep institutional commitment, these projects create sustainable pathways for lasting clinical improvements.” Full

Autism Awareness Month Spotlight: From PCORnet® Data Reports to Patient-Centered Research Results

(4/17, PCORnet Blog) comments “April, celebrated as Autism Awareness Month, offers an excellent opportunity to highlight the vital role PCORnet® plays in supporting research on intellectual and developmental disabilities (IDD). A recent data report shows the capacity of the PCORnet infrastructure to support such research, revealing that clinical sites in PCORnet® Clinical Research Networks (CRNs) provide services to over 300,000 individuals with autism and more than one million patients with attention deficit hyperactivity disorder (ADHD).” Full

EU HTA Regulation: Don’t Forget About Vaccines, Industry Warns

(4/18, Eliza Slawther, Pink Sheet) reports “...Vaccines will fall within the scope of the new EU Health Technology Assessment (HTA) Regulation from 2030, but industry wants changes to be made to the methods used to perform the joint clinical assessments (JCAs) that will be required under the legislation for these products.” Subscription Required